Related references
Note: Only part of the references are listed.Prodigiosins from a marine sponge-associated actinomycete attenuate HCl/ethanol-induced gastric lesion via antioxidant and anti-inflammatory mechanisms
Mohamed S. Abdelfattah et al.
PLOS ONE (2019)
y Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
Mohammed I. Y. Elmallah et al.
CANCERS (2019)
Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by Glycosylation
Olivier Micheau
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Heliomycin and tetracinomycin D: anthraquinone derivatives with histone deacetylase inhibitory activity from marine sponge-associated Streptomyces sp SP9
Mohamed Saleh Abdelfattah et al.
3 BIOTECH (2018)
Heliomycin and tetracinomycin D: anthraquinone derivatives with histone deacetylase inhibitory activity from marine sponge-associated Streptomyces sp SP9
Mohamed Saleh Abdelfattah et al.
3 BIOTECH (2018)
Antimicrobial aromatic polyketides: a review of their antimicrobial properties and potential use in plant disease control
Jae Woo Han et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2018)
TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress
Florent Dufour et al.
ONCOTARGET (2017)
Sharkquinone, a new ana-quinonoid tetracene derivative from marine-derived Streptomyces sp EGY1 with TRAIL resistance-overcoming activity
Mohamed S. Abdelfattah et al.
JOURNAL OF NATURAL MEDICINES (2017)
Marine actinomycete crude extracts with potent TRAIL-resistance overcoming activity against breast cancer cells
Mohammed I. Y. Elmallah et al.
ONCOLOGY REPORTS (2017)
Neo-actinomycins A and B, natural actinomycins bearing the 5H-oxazolo[4,5-b] phenoxazine chromophore, from the marine-derived Streptomyces sp IMB094
Qiang Wang et al.
SCIENTIFIC REPORTS (2017)
Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study
Yun Leng et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Pyrrole: An emerging scaffold for construction of valuable therapeutic agents
Somnath S. Gholap
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs
Ying Huang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL
Scott McComb et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in cancer cells
Cristina Florean et al.
ONCOTARGET (2016)
YM155 sensitizes TRAIL-induced apoptosis through cathepsin S-dependent down-regulation of Mcl-1 and NF-κB-mediated down-regulation of c-FLIP expression in human renal carcinoma Caki cells
Seon Min Woo et al.
ONCOTARGET (2016)
Isolation and characterization of marine-derived actinomycetes with cytotoxic activity from the Red Sea coast
Mohamed Saleh Abdelfattah et al.
ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE (2016)
Prodigiosin and its potential applications
N. Darshan et al.
JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE (2015)
Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
Mohammed I. Y. Elmallah et al.
MARINE DRUGS (2015)
Isolation and characterization of multifunctional Streptomyces species with antimicrobial, nematicidal and phytohormone activities from marine environments in Egypt
Ferial M. Rashad et al.
MICROBIOLOGICAL RESEARCH (2015)
YM155 sensitizes triple- negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation
Marzia Pennati et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Actinomycetes from Red Sea Sponges: Sources for Chemical and Phylogenetic Diversity
Usama Ramadan Abdelmohsen et al.
MARINE DRUGS (2014)
Death receptors as targets in cancer
O. Micheau et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
A new bioactive aminophenoxazinone alkaloid from a marine-derived actinomycete
Mohamed S. Abdelfattah
NATURAL PRODUCT RESEARCH (2013)
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
L. Y. Dimberg et al.
ONCOGENE (2013)
TRAIL on trial: preclinical advances in cancer therapy
Daniel W. Stuckey et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Regulation of the human TRAIL gene
Joshua E. Allen et al.
CANCER BIOLOGY & THERAPY (2012)
Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells
Guillaume Jacquemin et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Resistance to TRAIL and how to surmount it
Danijela Maksimovic-Ivanic et al.
IMMUNOLOGIC RESEARCH (2012)
TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies
Christian T. Hellwig et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Mitochondria: master regulators of danger signalling
Lorenzo Galluzzi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Marine actinomycetes: An ongoing source of novel bioactive metabolites
Ramesh Subramani et al.
MICROBIOLOGICAL RESEARCH (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level
A. Morizot et al.
CELL DEATH AND DIFFERENTIATION (2011)
Assessment of resistomycin, as an anticancer compound isolated and characterized from Streptomyces aurantiacus AAA5
Rajendran Vijayabharathi et al.
JOURNAL OF MICROBIOLOGY (2011)
Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion
Sarah Shirley et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2011)
Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells?
Guillaume Jacquemin et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Pitucamycin: Structural Merger of a Phenoxazinone with an Epoxyquinone Antibiotic
Patricia Bezerra Gomes et al.
JOURNAL OF NATURAL PRODUCTS (2010)
Phenoxazine Derivatives Suppress the Infections Caused by Herpes Simplex Virus Type-1 and Herpes Simplex Virus Type-2 Intravaginally Inoculated Into Mice
Kyoko Hayashi et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2010)
Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5
Marine E. Gasparian et al.
APOPTOSIS (2009)
TRAIL-enhancing activity of Erythrinan alkaloids from Erythrina velutina
Masaaki Ozawa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Antitumor Compounds from Marine Actinomycetes
Carlos Olano et al.
MARINE DRUGS (2009)
Mansoquinone: Isolation and structure elucidation of new antibacterial aromatic polyketides from terrestrial Streptomyces Sp Eg5
Mohamed S. Abdelfattah
NATURAL PRODUCT RESEARCH (2009)
β-Sitosterol sensitizes MDA-MB-231 cells to TRAIL-induced apoptosis
Cheol Park et al.
ACTA PHARMACOLOGICA SINICA (2008)
Ligand-based targeting of apoptosis in cancer: The potential of recombinant human apoptosis ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL)
Avi Ashkenazi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
TRAIL Resistance of Breast Cancer Cells Is Associated with Constitutive Endocytosis of Death Receptors 4 and 5
Yaqin Zhang et al.
MOLECULAR CANCER RESEARCH (2008)
Studies on search for bioactive natural products targeting TRAIL signaling leading to tumor cell apoptosis
Mastimi Ishibashi et al.
MEDICINAL RESEARCH REVIEWS (2008)
Marine actinobacteria: new opportunities for natural product search and discovery
Alan T. Bull et al.
TRENDS IN MICROBIOLOGY (2007)
TRAIL in cancer therapy:: present and future challenges
Delphine Merino et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4
Robyn T. Sussman et al.
CANCER BIOLOGY & THERAPY (2007)
Elloxazinones A and B, new aminophenoxazinones from Streptomyces griseus Acta 2871
Ellen Graf et al.
JOURNAL OF ANTIBIOTICS (2007)
Developing a new resource for drug discovery: marine actinomycete bacteria
William Fenical et al.
NATURE CHEMICAL BIOLOGY (2006)
Biogeography of the marine actinomycete Salinispora
Paul R. Jensen et al.
ENVIRONMENTAL MICROBIOLOGY (2006)
Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2
Delphine Merino et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay
Saskia A. G. M. Cillessen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Diversity of actinomycetes isolated from Challenger Deep sediment (10,898 m) from the Mariana Trench
Wasu Pathom-aree et al.
EXTREMOPHILES (2006)
1-hydroxy-1-norresistomycin and resistoflavin methyl ether: New antibiotics from marine-derived streptomycetes
I Kock et al.
JOURNAL OF ANTIBIOTICS (2005)
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
LD Zhang et al.
CANCER GENE THERAPY (2005)
Marine actinomycetes as a source of novel secondary metabolites
HP Fiedler et al.
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2005)
Isolation and characterization of novel marine-derived actinomycete taxa rich in bioactive metabolites
NA Magarvey et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2004)
TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid, and Bax but differentially regulate events downstream from truncated Bid
AB Werner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Apoptosis: A link between cancer genetics and chemotherapy
RW Johnstone et al.
CELL (2002)
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
MR Sprick et al.
IMMUNITY (2000)
TRAIL receptor-2 signals apoptosis through FADD and caspase-8
JL Bodmer et al.
NATURE CELL BIOLOGY (2000)
Share Paper
